A Bayesian multi‐risks survival (MRS) model in the presence of double censorings

DOI10.1111/biom.13228zbMath1520.62176OpenAlexW3004278418WikidataQ93020959 ScholiaQ93020959MaRDI QIDQ6047772

No author found.

Publication date: 9 October 2023

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1111/biom.13228

zbMATH Keywords

MCMC methodsmultistate modeltime-to-event datasemi-competing risksprostate cancer dataBayesian model selection criteria

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites Work

• Unnamed Item
• Unnamed Item
• Bayesian gamma frailty models for survival data with semi-competing risks and treatment switching
• Maximum likelihood inference for the Cox regression model with applications to missing covariates
• Monte Carlo methods in Bayesian computation
• Bayesian path specific frailty models for multi-state survival data with applications
• Competing Risks and Multistate Models with R
• Estimating treatment effects with treatment switching via semicompeting risks models: an application to a colorectal cancer study
• Improving efficiency in clinical trials using auxiliary information: Application of a multi‐state cure model
• The Analysis of Failure Times in the Presence of Competing Risks
• A Predictive Approach to Model Selection
• The Collapsed Gibbs Sampler in Bayesian Computations with Applications to a Gene Regulation Problem
• A Proportional Hazards Model for the Subdistribution of a Competing Risk
• A New Bayesian Model for Survival Data with a Surviving Fraction
• Bayesian Measures of Model Complexity and Fit
• Adaptive Rejection Sampling for Gibbs Sampling
• On the Use of Cause-Specific Failure and Conditional Failure Probabilities: Examples From Clinical Oncology Data

This page was built for publication: A Bayesian multi‐risks survival (MRS) model in the presence of double censorings